Findit, Inc. (FDIT)
| Previous Close | 0.0391 |
| Open | 0.0380 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0380 - 0.0380 |
| 52 Week Range | 0.0101 - 0.0850 |
| Volume | |
| Avg. Volume | 58,443 |
| Market Cap | 36.304M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0000 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIREBioRegenx to Showcase Innovative Health Solutions at 36th Annual Roth Conference
CHATTANOOGA, TN / ACCESSWIRE / March 14, 2024 / BioRegenx, Inc . (OTC PINK:FDIT) is proud to announce its participation as an exhibitor in the esteemed Roth Emerging Brand Showcase at the 36th Annual Roth Conference. The conference is scheduled to ...
- ACCESSWIRE
CORRECTION FROM SOURCE: BioRegenx, Inc. Completes Merger into FindIt, Inc. and Launches Updated Version of the GlycoCheck HD CapiScope
(This release corrects the release that posted earlier on March 13, 2024 to update the 1st paragraph grammatical update, 4th paragraph relating to the DocSun information, and update of company contact information) CHATTANOOGA, TN / ACCESSWIRE / March ...
ACCESSWIREBioRegenx,Inc. Completes Merger into FindIt, Inc. and Launches Updated Version of the GlycoCheck HD CapiScope
CHATTANOOGA, TN / ACCESSWIRE / March 13, 2024 / On March 8, 2024, the merger ofBioRegenx , Inc. into Atlanta GA/ Findit, Inc. (OTC PINK:FDIT) was cleared by the SEC on January 17, 2024 and went effective with the State of Nevada, along with the ...
